Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine vs Mesalazine for Postoperative Crohn's Disease Relapse
NCT00946946Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Feb 2002
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of azathioprine in Crohn's disease, sponsored by Dr. Falk Pharma GmbH. Started Feb 2002; status: completed.
02
Drugs
azathioprine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00946946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00946946.